University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM

Not Applicable

Withdrawn

Conditions: Type 2 Diabetes

Interventions: Drug: Placebo
Drug: Pramlintide acetate

First Posted Date: 2008-08-11

Last Posted Date: 2021-07-22

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT00732147

0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma

Phase 2

Terminated

Conditions: Melanoma (Skin)

Interventions: Drug: pentamidine

First Posted Date: 2008-08-08

Last Posted Date: 2019-08-16

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 6

Registration Number: NCT00729807

Locations: 🇺🇸
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States

An Integrated Approach to Smoking Cessation in Severe Mental Illness (SMI)

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: BTSCS

First Posted Date: 2008-06-04

Last Posted Date: 2020-04-06

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 219

Registration Number: NCT00690131

Locations: 🇺🇸
University of Maryland Baltimore, Baltimore, Maryland, United States
🇺🇸
Harbor City Unlimited, Baltimore, Maryland, United States
🇺🇸
New Ventures, Sheppard Pratt, Timonium, Maryland, United States

Evaluation of Renal Drug Transport in Healthy Volunteers

Not Applicable

Completed

Conditions: Kidney Disease

Interventions: Drug: probenecid

First Posted Date: 2008-06-04

Last Posted Date: 2021-05-11

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 10

Registration Number: NCT00690014

Locations: 🇺🇸
University of Maryland GCRC, Baltimore, Maryland, United States

Biomarker Study of Acamprosate in Schizophrenia

Phase 4

Completed

Conditions: Schizoaffective Disorder
Schizophrenia

Interventions: Drug: Acamprosate

First Posted Date: 2008-06-02

Last Posted Date: 2019-09-25

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 36

Registration Number: NCT00688324

Locations: 🇺🇸
VA Maryland Health Care System, Baltimore, Maryland, United States
🇺🇸
Keypoint Community Mental Health Centers- Dundalk, Baltimore, Maryland, United States
🇺🇸
Maryland Psychiatric Research Center, Baltimore, Maryland, United States

and more 1 locations

Knowledge and Perception of Smoking Risks/Consequences

Completed

Conditions: Schizophrenia
Cigarette Smoking

First Posted Date: 2008-05-29

Last Posted Date: 2019-11-04

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 200

Registration Number: NCT00686101

Locations: 🇺🇸
National Institute on Drug Abuse (Johns Hopkins Bayview Campus), Baltimore, Maryland, United States
🇺🇸
Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, Maryland, United States

Aging, Lifestyle and Inflammation in Veterans Exercising

Not Applicable

Active, not recruiting

Conditions: Aging
Metabolism
Exercise
Inflammation

Interventions: Behavioral: Weight loss and aerobic exercise training

First Posted Date: 2008-04-25

Last Posted Date: 2023-11-13

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 100

Registration Number: NCT00667030

Locations: 🇺🇸
University of Maryland; Baltimore VA Medical Center, Baltimore, Maryland, United States

Familial Schizophrenia and Spectrum Personality Disorders

Completed

Conditions: Schizophrenia

First Posted Date: 2008-04-24

Last Posted Date: 2021-05-03

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 539

Registration Number: NCT00666146

Locations: 🇺🇸
Community Mental Health Centers, Baltimore, Maryland, United States
🇺🇸
VA Medical Center, Baltimore, Maryland, United States
🇺🇸
University of Maryland, Baltimore, Catonsville, Maryland, United States

Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes

Completed

Conditions: Bipolar
Schizophrenia

Interventions: Other: This is an observational study model that is family based

First Posted Date: 2008-04-24

Last Posted Date: 2021-05-03

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 3500

Registration Number: NCT00666432

Locations: 🇺🇸
Wayne State University School of Medicine, Detroit, Michigan, United States
🇺🇸
Hartford Hospital- The Institute of Living, Hartford, Connecticut, United States
🇺🇸
Center for Cognitive Medicine, Chicago, Illinois, United States

and more 3 locations

Heredity and Phenotype Intervention (HAPI) Heart Study

Not Applicable

Completed

Conditions: Cardiovascular Diseases

First Posted Date: 2008-04-22

Last Posted Date: 2022-07-26

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 868

Registration Number: NCT00664040

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy